Table 1.

Patients' characteristics

Characteristicsn%
Sex
 Male943
 Female1257
Age, y
 Median (range)51 (27–74)
ECOG performance status
 01362
 1838
Previous lines of systemic therapies
 Median (range)3 (0–5)
Tumor type
 Melanoma11
 Ovarian cancer4
 Gastrointestinal stromal tumor2
 Breast cancer1
 Colon cancer1
 Merkel cell carcinoma1
Inclusion in a phase I triala
 Number of parents17

Abbreviation: ECOG, Eastern Cooperative Oncology Group.

  • aApproved by the Kremlin Bicêtre Hospital Ethics Committee (n° 07-019) and the Agence Française de Sécurité Sanitaire des Produits de Santé (n° A70385-27) in 2007, N° EudraCT: 2007-001699-35. All patients signed an informed consent for this study.